Leaderboards/Coronary Artery Anomalies

Coronary Artery Anomalies

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Yogi Andrew Taruk Padang
Unknown
2
Richard C. V. Tyser
Wellcome/MRC Cambridge Stem Cell Institute
3
Rocco Antonio Montone
Agostino Gemelli University Polyclinic
4
Rebecca A. Porritt
Sanford Burnham Prebys Medical Discovery Institute
5
Jisheng Sun
Emory University
6
Ashish Babarao Lakhote
Vardhman Mahavir Medical College & Safdarjung Hospital
7
Vedant Pargaonkar
Stanford Medicine
8
Abhishek Chakraborty
Le Bonheur Children's Hospital
9
Domenico Sirico
University of Padua
10
Vincent Knight-Schrijver
Wellcome/MRC Cambridge Stem Cell Institute

Rising Stars Papers

1
Giant Left Atrial Myxoma Revealed by Neurological Manifestation in a Young Female Patient
International Journal of Innovative Science and Research Technology (IJISRT)|2024
242 cit.
2
Exposome in ischaemic heart disease: beyond traditional risk factors
European Heart Journal|2024
90 cit.
3
An update on the mechanisms of Takotsubo syndrome: “At the end an acute coronary syndrome”
Journal of Molecular and Cellular Cardiology|2024
29 cit.
4
Stratified treatment of myocardial infarction with non-obstructive coronary arteries: the PROMISE trial
European Heart Journal|2025
19 cit.
5
ptx3a+ fibroblast/epicardial cells provide a transient macrophage niche to promote heart regeneration
Cell Reports|2024
17 cit.
6
Predicting the response to acetylcholine in ischemia or infarction with non-obstructive coronary arteries: The ABCD score
Atherosclerosis|2024
13 cit.
7
Sex‐Related Differences in the Prognostic Role of Acetylcholine Provocation Testing
Journal of the American Heart Association|2025
6 cit.
8
Angina with non-obstructive coronary arteries: a success story
European Heart Journal|2025
4 cit.
9
Right ventricular-pulmonary artery coupling assessed by two-dimensional strain predicts in-hospital complications in Takotsubo syndrome
International Journal of Cardiology|2025
3 cit.
10
Routine diagnosis of ANOCA/INOCA: pros and cons
EuroIntervention|2025
3 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Patricia Rojo
National University of Rosario
2
Yulius Patimang
Unknown
3
Ximena Ibarra-Soria
Relay Therapeutics (United States)
4
Sven Reischauer
Universitätsklinikum Gießen und Marburg
5
Alfredo Tagarro
Universidad Europea
6
Katrijn Jansen
Newcastle upon Tyne Hospitals NHS Foundation Trust
7
A. J. Agopian
The University of Texas Health Science Center at Houston
8
Bernard Cosyns
Vrije Universiteit Brussel
9
Sunny Zhang
University of California System
10
Joshua Scheers-Masters
Maimonides Medical Center

Emerging Leaders Papers

1
Giant Left Atrial Myxoma Revealed by Neurological Manifestation in a Young Female Patient
International Journal of Innovative Science and Research Technology (IJISRT)|2024
242 cit.
2
Cardiovascular Complications of Down Syndrome: Scoping Review and Expert Consensus
Circulation|2023
119 cit.
3
Machine learning outperformed logistic regression classification even with limit sample size: A model to predict pediatric HIV mortality and clinical progression to AIDS
PLoS ONE|2022
32 cit.
4
Nirsevimab para la prevención de la enfermedad por virus respiratorio sincitial en niños. Posicionamiento de la Sociedad Española de Infectología Pediátrica
Anales de Pediatría|2023
29 cit.
5
A transcriptional and regulatory map of mouse somite maturation
Developmental Cell|2023
16 cit.
6
High mortality following early initiation of antiretroviral therapy in infants living with HIV from three African countries
EClinicalMedicine|2024
16 cit.
7
Ventricular assist devices in transposition and failing systemic right ventricle: role of tricuspid valve replacement
European Journal of Cardio-Thoracic Surgery|2022
12 cit.
8
Treatments for multi-system inflammatory syndrome in children — discharge, fever, and second-line therapies
European Journal of Pediatrics|2022
10 cit.
9
Survival of neonates, infants, and children with birth defects: a population-based study in Texas, 1999–2018
The Lancet Regional Health - Americas|2023
10 cit.
10
Epidemiology of Nonsyndromic, Orofacial Clefts in Texas: Differences by Cleft Type and Presence of Additional Defects
The Cleft Palate-Craniofacial Journal|2022
8 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Gary D. Webb
Cincinnati Children's Hospital Medical Center
2
William C. Roberts
National Institutes of Health
3
Kenneth D. Poss
Council of Science Editors
4
Robert H. Anderson
Newcastle University
5
Henry M. Sucov
University of Charleston
6
Renu Virmani
CVPath Institute
7
Marian E. Melish
Kapiolani Medical Center for Women and Children
8
Didier Y. R. Stainier
Max Planck Institute for Heart and Lung Research
9
Jane C. Burns
Rady Children's Hospital-San Diego
10
Deepak Srivastava
Gladstone Institutes

Current Senior Leaders Papers

1
Pathology of Drug-Eluting Stents in Humans
Journal of the American College of Cardiology|2006
2.7k cit.
2
Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors
Cell|2010
2.5k cit.
3
Pathology of the Vulnerable Plaque
Journal of the American College of Cardiology|2006
2.3k cit.
4
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
Circulation|2008
2.1k cit.
5
Heart Regeneration in Zebrafish
Science|2002
2k cit.
6
miR-126 Regulates Angiogenic Signaling and Vascular Integrity
Developmental Cell|2008
1.7k cit.
7
miR-145 and miR-143 regulate smooth muscle cell fate and plasticity
Nature|2009
1.6k cit.
8
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
Journal of the American College of Cardiology|2008
1.5k cit.
9
Mutations in NOTCH1 cause aortic valve disease
Nature|2005
1.5k cit.
10
Intraplaque Hemorrhage and Progression of Coronary Atheroma
New England Journal of Medicine|2003
1.5k cit.

Reagents for Coronary Artery Anomalies

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

🌟 All-Time

Most validated

Cell Signaling Technology

METTL7B (F6K2W) Rabbit Monoclonal Antibody

#17206$161,376
View Evidence →
Sigma-Aldrich

Monoclonal Anti-Actin (alpha-Sarcomeric) antibody produced in mouse

#A2172
View Evidence →
Santa Cruz BiotechnologyEvidence 61

PCNA (PC10)

#sc-56
View Evidence →